Open Access
Open access
volume 21 issue 1 publication number 40

Elevated level of multibranched complex glycan reveals an allergic tolerance status

Ran Zhao 1, 2, 3
Chao Wang 1
Feidie Li 1
Zeyu Zeng 1
Yijing Hu 1
Xiaoyan Dong 1, 2, 3
Publication typeJournal Article
Publication date2024-06-08
scimago Q1
wos Q2
SJR0.962
CiteScore4.3
Impact factor3.3
ISSN15426416, 15590275
Abstract
Background

Allergen immunotherapy (AIT) is the only disease-modifying therapy that can achieve immune tolerance in patients through long-term allergen stimulation. Glycans play crucial roles in allergic disease, but no information on changes in glycosylation related to an allergic tolerance status has been reported.

Methods

Fifty-seven patients with house dust mite (HDM) allergies were enrolled. Twenty-eight patients were not treated with AIT, 19 patients had just entered the AIT maintenance treatment phase, and 10 patients had been in the AIT maintenance phase for more than 1 year. Serum protein N-glycans were analyzed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), which included linkage-specific sialylation information.

Results

Eighty-four N-glycans were identified in all three groups. Compared with the patients treated without AIT, the patients treated with AIT for a shorter time showed downregulated expression of high-mannose glycans and upregulated expression of α2,6 sialic acid. The patients treated with AIT in the maintenance phase for over 1 year, which was considered the start of immunological tolerance, showed downregulated expression of biantennary N-glycans and upregulated expression of multibranched and complex N-glycans. Nine N-glycans were changed between allergic and allergic-tolerant patients.

Conclusions

The glycan form changed from mannose to a more complex type as treatment time increased, and multibranched complex glycans have the potential to be used as a monitoring indicator of immune tolerance. This serum N-glycome analysis provided important information for a deeper understanding of AIT treatment at the molecular level.

Found 
Found 

Top-30

Journals

1
2
Immunological Reviews
2 publications, 66.67%
Microchemical Journal
1 publication, 33.33%
1
2

Publishers

1
2
Wiley
2 publications, 66.67%
Elsevier
1 publication, 33.33%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3
Share
Cite this
GOST |
Cite this
GOST Copy
Zhao R. et al. Elevated level of multibranched complex glycan reveals an allergic tolerance status // Clinical Proteomics. 2024. Vol. 21. No. 1. 40
GOST all authors (up to 50) Copy
Zhao R., Wang C., Li F., Zeng Z., Hu Y., Dong X. Elevated level of multibranched complex glycan reveals an allergic tolerance status // Clinical Proteomics. 2024. Vol. 21. No. 1. 40
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1186/s12014-024-09491-8
UR - https://clinicalproteomicsjournal.biomedcentral.com/articles/10.1186/s12014-024-09491-8
TI - Elevated level of multibranched complex glycan reveals an allergic tolerance status
T2 - Clinical Proteomics
AU - Zhao, Ran
AU - Wang, Chao
AU - Li, Feidie
AU - Zeng, Zeyu
AU - Hu, Yijing
AU - Dong, Xiaoyan
PY - 2024
DA - 2024/06/08
PB - Springer Nature
IS - 1
VL - 21
PMID - 38849742
SN - 1542-6416
SN - 1559-0275
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Zhao,
author = {Ran Zhao and Chao Wang and Feidie Li and Zeyu Zeng and Yijing Hu and Xiaoyan Dong},
title = {Elevated level of multibranched complex glycan reveals an allergic tolerance status},
journal = {Clinical Proteomics},
year = {2024},
volume = {21},
publisher = {Springer Nature},
month = {jun},
url = {https://clinicalproteomicsjournal.biomedcentral.com/articles/10.1186/s12014-024-09491-8},
number = {1},
pages = {40},
doi = {10.1186/s12014-024-09491-8}
}